Camlica H - Search Results

1

Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial.

Tas F, Argon A, Camlica H, Topuz E. Tas F, et al. Among authors: camlica h. Melanoma Res. 2005 Dec;15(6):543-8. doi: 10.1097/00008390-200512000-00010. Melanoma Res. 2005. PMID: 16314741 Clinical Trial.

2

Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.

Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E. Tas F, et al. Among authors: camlica h. Melanoma Res. 2006 Oct;16(5):405-11. doi: 10.1097/01.cmr.0000222598.27438.82. Melanoma Res. 2006. PMID: 17013089

3

Malignant melanoma in Turkey: a single institution's experience on 475 cases.

Tas F, Kurul S, Camlica H, Topuz E. Tas F, et al. Among authors: camlica h. Jpn J Clin Oncol. 2006 Dec;36(12):794-9. doi: 10.1093/jjco/hyl114. Epub 2006 Oct 23. Jpn J Clin Oncol. 2006. PMID: 17060409

4

Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma: a single institution's experience.

Tas F, Kurul S, Camlica H, Topuz E. Tas F, et al. Among authors: camlica h. Med Oncol. 2006;23(4):471-7. doi: 10.1385/MO:23:4:471. Med Oncol. 2006. PMID: 17303905 Clinical Trial.

5

Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.

Tas F, Derin D, Guney N, Camlica H, Aydiner A, Topuz E. Tas F, et al. Among authors: camlica h. Lung Cancer. 2007 Jul;57(1):79-83. doi: 10.1016/j.lungcan.2007.02.009. Epub 2007 Mar 26. Lung Cancer. 2007. PMID: 17383768

6

Temozolomide in combination with fotemustine in patients with metastatic melanoma.

Tas F, Camlica H, Topuz E. Tas F, et al. Among authors: camlica h. Cancer Chemother Pharmacol. 2008 Jul;62(2):293-8. doi: 10.1007/s00280-007-0606-5. Epub 2007 Oct 2. Cancer Chemother Pharmacol. 2008. PMID: 17909803 Clinical Trial.

7

Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer.

Tas F, Guney N, Derin D, Camlica H, Aydiner A, Topuz E. Tas F, et al. Among authors: camlica h. Invest New Drugs. 2008 Aug;26(4):363-8. doi: 10.1007/s10637-007-9110-3. Epub 2007 Dec 29. Invest New Drugs. 2008. PMID: 18165864 Clinical Trial.

8

Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.

Tas F, Demir C, Camlica H, Ustuner Z, Topuz E. Tas F, et al. Among authors: camlica h. Med Oncol. 2004;21(3):233-40. doi: 10.1385/MO:21:3:233. Med Oncol. 2004. PMID: 15456950 Clinical Trial.

9

Serum bcl-2 and survivin levels in melanoma.

Tas F, Duranyildiz D, Argon A, Oguz H, Camlica H, Yasasever V, Topuz E. Tas F, et al. Among authors: camlica h. Melanoma Res. 2004 Dec;14(6):543-6. doi: 10.1097/00008390-200412000-00017. Melanoma Res. 2004. PMID: 15577328

10

Apoptosis of lymphocytes in peripheral blood of patients with melanoma.

Tas F, Duranyildiz D, Argon A, Oguz H, Camlica H, Yasasever V, Topuz E. Tas F, et al. Among authors: camlica h. Med Oncol. 2005;22(2):177-81. doi: 10.1385/MO:22:2:177. Med Oncol. 2005. PMID: 15965281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page